Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Operating Leases (2019 - 2025)

Biomerica's Operating Leases history spans 7 years, with the latest figure at $373000.0 for Q3 2025.

  • Quarterly results put Operating Leases at $373000.0 for Q3 2025, down 47.24% from a year ago — trailing twelve months through Aug 2025 was $373000.0 (down 47.24% YoY), and the annual figure for FY2025 was $100000.0, down 78.21%.
  • Operating Leases for Q3 2025 was $373000.0 at Biomerica, up from $100000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.4 million in Q1 2022 to a low of $100000.0 in Q2 2025.
  • The 5-year median for Operating Leases is $901449.0 (2022), against an average of $860307.2.
  • The sharpest move saw Operating Leases rose 6.83% in 2022, then crashed 78.21% in 2025.
  • Year by year, Operating Leases stood at $1.2 million in 2021, then fell by 22.74% to $901449.0 in 2022, then grew by 3.94% to $937000.0 in 2023, then tumbled by 33.19% to $626000.0 in 2024, then crashed by 40.42% to $373000.0 in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $373000.0, $100000.0, and $193000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.